Manifest Wins First Place and $315,000 in the 2018 Edward L. Kaplan, ’71, New Venture Challenge

The Polsky Center for Entrepreneurship and Innovation at the University of Chicago is pleased to announce the winners of the 22nd annual Edward L. Kaplan, '71, New Venture Challenge (NVC),…

MassChallenge 2018 Cohort Announced

Two Polsky Center-connected companies, Oxalo Therapeutics and ImmunArtes, were accepted into the MassChallenge accelerator. Read the full article >>

The University of Chicago Program Links MBA Students and Scientists to Launch Startups

Oxalo Therapeutics combines the research of UChicago Medicine professor with Chicago Booth student to compete in Polsky Center programs. Read the full article >>

Finalists Announced for the 2018 Edward L. Kaplan, ’71, New Venture Challenge

Eleven teams have been selected to pitch their ventures during the finals of the Edward L. Kaplan, ’71, New Venture Challenge on Wednesday, May 30. The New Venture Challenge, a…

Innovation Fund Invests $575,000 in Biotech Companies

The University of Chicago Innovation Fund announced plans to invest up to $575,000 into three biotechnology companies—ImmunArtes, Onchilles Pharma, and Oxalo Therapeutics. These latest investments bring the Innovation Fund’s total…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.